Publication | Closed Access

RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways

Novel Galectin-3 InhibitorCancer ResearchSignaling PathwayPancreatic CancerMedicineImmunologySignaling PathwaysTumor SuppressorCancer BiologyCell BiologyCell SignalingTumor BiologyCancer Growth